Table 3.
Clinical Parameters, Baseline Versus 6 months
| Renal Denervation (n=23) | Controls (n=5) | |||||
|---|---|---|---|---|---|---|
| Baseline | 6 mo | P Value | Baseline | 6 mo | P Value | |
| BMI, kg/m2 | 28.12±3.58 (28.73) | 27.72±3.80 (28.40) | 0.709 | 26.90±2.81 (25.69) | 26.89±3.92 (24.22) | 1.000 |
| Heart rate, bpm | 71.04±12.77 (69) | 66.48±9.88 (67) | 0.016 | 76.20±13.99 (78) | 74.20±18.03 (66) | 0.343 |
| SBP, mm Hg | 161.96±19.09 (160) | 144.78±16.48 (143) | <0.0001 | 152.80±22.97 (150) | 145.00±13.64 (140) | 0.273 |
| DBP, mm Hg | 85.61±12.88 (83) | 80.39±11.93 (81) | 0.018 | 80.60±12.28 (78) | 71.00±7.35 (75) | 0.144 |
| Creatinine, mg/dL | 0.88±0.13 (0.88) | 0.92±0.20 (0.89) | 0.080 | 0.82±0.17 (0.77) | 0.82±0.13 (0.77) | 1.000 |
| GFR, mL/min per 1.73 m2 | 80.70±15.33 (80.50) | 79.09±17.03 (78.95) | 0.503 | 79.80±19.12 (73.30) | 80.39±18.56 (73.30) | 0.715 |
| Hematocrit, % | 39.9±3.3 (39.7) | 39.9±3.8 (40.2) | 0.819 | 37.8±3.6 (39.7) | 38.9±4.7 (39.9) | 0.498 |
| Antihypertensive drugs (n) | 4.78±1.48 (5) | 4.35±1.67 (4) | 0.083 | 4.80±0.84 (5) | 4.60±1.14 (5) | 0.655 |
Results expressed as mean±SD (median) or number (%). BMI indicates body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; GFR, glomerular filtration rate.